@article{Chessa_Piga_Floris_Mathieu_Cauli_2017, title={Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series}, volume={69}, url={https://www.reumatismo.org/reuma/article/view/1007}, DOI={10.4081/reumatismo.2017.1007}, abstractNote={Demyelinating syndrome (DS) is a rare manifestation of systemic lupus erythematosus (SLE) (1%) with high clinical heterogeneity and potentially severe prognosis. It can represent a diagnostic and therapeutic challenge for clinicians. A recent study described 5 different patterns of demyelinating disease presentation, characterised by specific clinical, laboratory and brain and spine magnetic resonance imaging abnormalities: 1) neuromyelitis optica; 2) neuromyelitis optica spectrum disorders; 3) DS prevalently involving the brain; 4) DS prevalently involving the brainstem; 5) clinically isolated syndrome. In this review we briefly discuss typical characteristics of each DS presentation in SLE and we describe 5 illustrative clinical cases, one for each subset of DS, considering both diagnostic and therapeutic options.}, number={4}, journal={Reumatismo}, author={Chessa, E. and Piga, M. and Floris, A. and Mathieu, A. and Cauli, A.}, year={2017}, month={Dec.}, pages={175–183} }